Emulate is a biotechnology company developing advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Register for Details

For more details on financing and valuation for Emulate, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Emulate's ticker symbol?

Emulate does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Emulate's stock price?

The stock price for Emulate will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Emulate Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/7/2021 Series E-1 and E-2 $409.37MM $XXX.XX $XXX.XX
8/16/2019 Series D $268.09MM $XXX.XX $XXX.XX
6/19/2018 Series C $185MM $XXX.XX $XXX.XX
10/20/2016 Series B $138.89MM $XXX.XX $XXX.XX
7/22/2014 Series A $40MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Emulate

Forge green plus iconForge green minus icon

What is Emulate funding to date?

Emulate has raised $202.31MM with the following series:
$40MM for Series A, $138.89MM for Series B, $185MM for Series C, $268.09MM for Series D, $409.37MM for Series E-1 and E-2, $40MM for Series A, $138.89MM for Series B, $185MM for Series C, $268.09MM for Series D, $409.37MM for Series E-1 and E-2.
Forge green plus iconForge green minus icon

When was Emulate founded?

Emulate was founded in 2014.
Forge green plus iconForge green minus icon

Can you invest in Emulate?

Emulate is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Emulate share pre-IPO?

If you own Emulate pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Emulate a publicly traded company?

Emulate is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Emulate in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector